SUNNYVALE, Calif., Sept. 16, 2011 /PRNewswire/ — Accuray
ARAY), the premier radiation oncology company, announced today
that its management is scheduled to present at the UBS Global Life
Sciences Conference in New York on Tuesday, September 20, 2011 at
4:30 p.m. ET/1:30 p.m. PT.
A live webcast of the presentation will be available online from
the investor relations page of the Company’s Web site at http://www.accuray.com. The
webcast replay of the presentation will begin approximately one
hour after the conclusion of the live presentation and will be
available for approximately 30 days.
Accuray Incorporated (Nasdaq:
ARAY), based in Sunnyvale, Calif., is the premier radiation
oncology company. Accuray develops, manufactures and sells
personalized, innovative treatment solutions that revolve around
the patient. Accuray’s game-changing technologies – the
CyberKnife System and TomoTherapy System – set the standard
of care with the aim of helping patients live longer, better lives.
To date, more than 200,000 patients worldwide have been treated
using the company’s technologies and more than 550 systems have
been installed in leading hospitals around the world. For more
information, please visit www.accuray.com.